A Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity

• Status: Terminated
• Trial end date: 2013-03-01
• Target enrollment: 0
• Participant gender: All

Summary

This study aims to compare outcomes in renal transplant recipients in the hispanic population based on their immunosuppressant regimens.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Loma Linda University
• Treatments: Cyclosporine; Cyclosporins; Tacrolimus

Criteria

Inclusion Criteria:

• Cadaveric or Living Donors

• 18 years old or greater

• Primary renal transplants

• Hispanic ethnicity

Exclusion Criteria:

• Prior renal transplant

• Multi-organ transplant

• Recipient with history of Diabetes Mellitus

• PRA > 20%

• Cold Ischemia Time > 24 hours